Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1992;12:736-744

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marotti, K. R.
Right arrow Articles by Melchior, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marotti, K. R.
Right arrow Articles by Melchior, G. W.

Arteriosclerosis and Thrombosis, Vol 12, 736-744, Copyright © 1992 by American Heart Association


ARTICLES

The role of cholesteryl ester transfer protein in primate apolipoprotein A-I metabolism. Insights from studies with transgenic mice

KR Marotti, CK Castle, RW Murray, EF Rehberg, HG Polites and GW Melchior
Molecular Biology Research and Metabolic Diseases Research, Upjohn Laboratories, Kalamazoo, MI 49001.

To assess the effects of cholesteryl ester transfer protein (CETP) on the primate lipoprotein profile, a transgenic mouse expressing cynomolgus monkey CETP was developed. The C57BL/6 mouse was used, and four lines expressing the primate CETP were established. The level of CETP activity in the plasma of the transgenic mice ranged from values similar to those obtained for the monkey to levels approximately sixfold higher than that in the normal monkey. When all of the lines were taken into consideration, there was a strong (r = -0.81 or higher, p less than 0.01) negative correlation between plasma CETP activity and total plasma cholesterol, plasma apolipoprotein (apo) A-I levels, and plasma apo A-I to apo B ratio. There was a strong positive correlation (r = 0.77) between plasma CETP activity and plasma apo B levels. The size of the apo A-I-containing lipoproteins was significantly reduced in mice with high plasma CETP activity, and that reduction in size was due to the absence of the larger (HDL1 and HDL2) apo A-I-containing particles in the plasma. When the transgenic mice were fed a high-fat, high-cholesterol diet, the effects of the diet on lipoprotein profile were more prominent in the CETP transgenic mice than the controls. The CETP transgenic mice had, for example, substantially higher plasma cholesterol and plasma apo B levels (p less than 0.01), and the apo B- containing lipoproteins were generally larger than those in the nontransgenic C57BL/6 mice consuming the same diet.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
Z. Zak, L. Lagrost, T. Gautier, D. Masson, V. Deckert, L. Duverneuil, J.-P. P. de Barros, N. Le Guern, L. Dumont, M. Schneider, et al.
Expression of simian CETP in normolipidemic Fisher rats has a profound effect on large sized apoE-containing HDL
J. Lipid Res., December 1, 2002; 43(12): 2164 - 2171.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. C. Escolà-Gil, J. Julve, A. Marzal-Casacuberta, J. Ordóñez-Llanos, F. González-Sastre, and F. Blanco-Vaca
ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance
J. Lipid Res., February 1, 2001; 42(2): 241 - 248.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
S. Jansen, J. Lopez-Miranda, P. Castro, F. Lopez-Segura, C. Marin, J. M Ordovas, E. Paz, J. Jimenez-Pereperez, F. Fuentes, and F. Perez-Jimenez
Low-fat and high-monounsaturated fatty acid diets decrease plasma cholesterol ester transfer protein concentrations in young, healthy, normolipemic men
Am. J. Clinical Nutrition, July 1, 2000; 72(1): 36 - 41.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. S. Plump, L. Masucci-Magoulas, C. Bruce, C. L. Bisgaier, J. L. Breslow, and A. R. Tall
Increased Atherosclerosis in ApoE and LDL Receptor Gene Knock-Out Mice as a Result of Human Cholesteryl Ester Transfer Protein Transgene Expression
Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 1105 - 1110.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. K. Castle, S. L. Kuiper, W. L. Blake, B. Paigen, K. R. Marotti, and G. W. Melchior
Remodeling of the HDL in NIDDM: a fundamental role for cholesteryl ester transfer protein
Am J Physiol Endocrinol Metab, June 1, 1998; 274(6): E1091 - E1098.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Liu, Y. L. Zhang, M. J. Spence, R. E. Vestal, P. M. Wallace, and D. S. Grass
Liver LDL Receptor mRNA Expression Is Decreased in Human ApoB/CETP Double Transgenic Mice and Is Regulated by Diet as Well as the Cytokine Oncostatin M
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2948 - 2954.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. V. Rodrigueza, K. D. Mazany, A. D. Essenburg, M. E. Pape, T. J. Rea, C. L. Bisgaier, and K. J. Williams
Large Versus Small Unilamellar Vesicles Mediate Reverse Cholesterol Transport In Vivo Into Two Distinct Hepatic Metabolic Pools : Implications for the Treatment of Atherosclerosis
Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 2132 - 2139.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. A. Kuivenhoven, P. de Knijff, J. M.A. Boer, H. A. Smalheer, G.-J. Botma, J. C. Seidell, J. J.P. Kastelein, and P. H. Pritchard
Heterogeneity at the CETP Gene Locus : Influence on Plasma CETP Concentrations and HDL Cholesterol Levels
Arterioscler Thromb Vasc Biol, March 1, 1997; 17(3): 560 - 568.
[Abstract] [Full Text]